checkAd
    Startseite > Aktien > Immunovant > Nachrichten
    Immunovant Aktie
    25,39
     
    USD
    -3,86 %
    -1,02 USD
    Letzter Kurs 02:00:00 Nasdaq
    25,38
     
    USD
    200 STK
    Geldkurs 31.05.24
    25,39
     
    USD
    600 STK
    Briefkurs 31.05.24
    ISIN: US45258J1025 · WKN: A2P5G1 · SYM: IMVT · USA

    Neueste Nachrichten

    Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024
    29.05.24 · globenewswire · Immunovant
    Immunovant Awarded U.S. Patent for IMVT-1402
    12.03.24 · globenewswire · Immunovant
    Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
    12.02.24 · globenewswire · Immunovant
    Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    03.01.24 · globenewswire · Immunovant
    Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
    20.12.23 · globenewswire · Immunovant
    Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
    28.11.23 · globenewswire · Immunovant
    Immunovant to Present at Upcoming Investor Conferences
    13.11.23 · globenewswire · Immunovant
    Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended September 30, 2023
    09.11.23 · globenewswire · Immunovant
    Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares
    02.10.23 · globenewswire · Immunovant
    Immunovant Announces Pricing of $450 Million Common Stock Financing
    28.09.23 · globenewswire · Immunovant
    Immunovant: Das steckt hinter dem Kursverdoppler
    27.09.23 · Sharedeals · Immunovant
    Immunovant Announces Proposed Offering of $300 Million of Common Stock
    26.09.23 · globenewswire · Immunovant